22157.jpg
Global CRISPR Gene Detection and Diagnostic Market Research Report 2022: Cost, Accuracy and Speed, The Economies of Multiplexing with Nucleic Acids, The New Agriculture, Pandemics and Pathogens
27 juil. 2022 06h08 HE | Research and Markets
Dublin, July 27, 2022 (GLOBE NEWSWIRE) -- The "CRISPR Gene Detection and Diagnostic Markets by Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides"...
Insights on the Genome Editing Global Market to 2027 - Growing Cases of Cancer and Other Genetic Disorders is Driving Growth
22 juin 2022 06h03 HE | Research and Markets
Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "Genome Editing Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. Genome editing is a method of making...
Intellia.jpg
Intellia Therapeutics Presents Preclinical Data Demonstrating Advancements in its CRISPR-Engineered Allogeneic Platform at the 2022 Keystone Symposia’s Precision Genome Engineering Conference
02 mai 2022 07h30 HE | Intellia Therapeutics, Inc.
Data highlight proprietary allogeneic cell engineering platform capable of creating immune-evading T cells and deployable for TCR-T and CAR-T cell therapyFindings support recent development candidate...
GMILogo_Vertical-Gradient.png
Rat Model Market revenue worth USD 2.3 Billion by 2028, Says Global market insights inc.
26 avr. 2022 05h15 HE | Global Market Insights Inc.
Selbyville, Delaware, April 26, 2022 (GLOBE NEWSWIRE) -- The rat model market value is projected to reach USD 2.3 billion by 2028, according to a new research report by Global Market Insights Inc....
Global CRISPR Technology Market Analysis 2022-2026, Featuring Profiles of Thermo Fisher Scientific, CRISPR Therapeutics, GenScript Biotech, Editas Medicine and Intellia Therapeutics
19 avr. 2022 04h08 HE | Research and Markets
Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "CRISPR Technology Global Market Report 2022, By Product Type, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering....
22157.jpg
Worldwide Cell and Gene Therapy Bioassay Services Industry to 2030 - Featuring CCRM, Nexelis and Pacific BioLabs Among Others
22 mars 2022 06h48 HE | Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Bioassay Services Market by Type of Therapy, Therapeutic Area, Scale of Operation and Geography: Industry Trends and Global...
22157.jpg
Global Gene Editing Beyond CRISPR Market (2022 to 2035) - Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies
22 mars 2022 06h13 HE | Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies:...
Global Genomics Market Forecast to Register Compound Annual Growth of 18.2% to Reach $63.50 Billion in 2026
10 mars 2022 05h08 HE | Research and Markets
Dublin, March 10, 2022 (GLOBE NEWSWIRE) -- The "Genomics Global Market Report 2022, By Product Type, By Process, By End User" report has been added to ResearchAndMarkets.com's offering. The global...
Intellia.jpg
Intellia Therapeutics Receives U.S. FDA Orphan Drug Designation for NTLA-5001 for the Treatment of Acute Myeloid Leukemia 
09 mars 2022 16h01 HE | Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., March 09, 2022 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative...
GMILogo_Vertical-Gradient.png
Animal Model Market revenue to cross $30.6 billion by 2028, Says Global Market Insights Inc.
08 mars 2022 05h30 HE | Global Market Insights Inc.
Selbyville, Delaware, March 08, 2022 (GLOBE NEWSWIRE) -- The animal model market value is projected to surpass USD 30.6 billion by 2028, according to a new research report by Global Market...